Our clinical team, featuring top U.S. specialists in childhood cancer, includes:
- Allen Korenblit, MD, brings more than 20 years experience to the treatment of pediatric blood disorders and cancer. Korenblit directs the Sickle Cell Disease Program, the Bone and Soft Tissue Sarcoma Program and the Leukemia and Lymphoma Disease Program.
- Paul M. Kent, MD
- Mindy L. Simpson, MD, treats patients with all types of blood disorders and pediatric cancers. She is active in clinical and laboratory research, with a primary focus on bleeding and clotting disorders
Our faculty members belong to the Children's Oncology Group, a National Cancer Institute-supported clinical trials cooperative group devoted exclusively to childhood and adolescent cancer research. The research includes phase I, II and III studies involving patients with a variety of cancers, including Ewing sarcoma, Hodgkin's disease, leukemia, Wilms tumor, medulloblastoma, neuroblastoma and lymphoma. Allen Korenblit, MD, is principal investigator at Rush for the pediatric oncology group.